Silvia Taylor | Senior Vice President-Global Corporate Affairs and Investor Relations |
Stan Erck | President and Chief Executive Officer |
Filip Dubovsky | Chief Medical Officer |
John Trizzino | Chief Commercial Officer and Chief Business Officer |
Jim Kelly | Chief Financial Officer and Treasurer |
Greg Glenn | President-Research and Development |
Georgi Yordanov | Cowen and Co |
Roger Song | Jefferies |
Mayank Mamtani | B. Riley |
Eric Joseph | JPMorgan |
Alec Stranahan | Bank of America |
Good morning and welcome to Novavax Second Quarter 2022 Financial Results and Operational Highlights Conference Call. All participants will be in listen-only mode. [Operator Instructions] After today’s presentation, there will an opportunity to ask questions. [Operator Instructions] Please note, this event is being recorded. I would now like to turn the conference over to Silvia Taylor, Senior Vice President of Global Corporate Affairs and Investor Relations.